ANAVEX LIFE SCIENCES CORP. Gain (Loss) on Extinguishment of Debt
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Gain (Loss) on Extinguishment of Debt of $59.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-08-06
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $59.00K.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for fiscal 2019 was $115.76K.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for fiscal 2016 was $61.20K, a 27.86% decline from fiscal 2015.
- ANAVEX LIFE SCIENCES CORP. gain (loss) on extinguishment of debt for fiscal 2015 was $84.84K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 89 month | Gain (Loss) on Extinguishment of Debt 92 month | Gain (Loss) on Extinguishment of Debt 95 month | Gain (Loss) on Extinguishment of Debt 98 month | Gain (Loss) on Extinguishment of Debt 101 month | Gain (Loss) on Extinguishment of Debt 104 month | Gain (Loss) on Extinguishment of Debt 107 month | Gain (Loss) on Extinguishment of Debt 110 month | Gain (Loss) on Extinguishment of Debt 113 month | Gain (Loss) on Extinguishment of Debt 116 month | Gain (Loss) on Extinguishment of Debt 119 month | Gain (Loss) on Extinguishment of Debt 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $59.00K 10-Q · filed 2024-08-06 | $59.00K 10-Q · filed 2024-08-06 | ||||||||||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | ||||||||||||||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $0.00 derived: sum of 2 quarters · filed 2020-12-28 | $0.00 10-K · filed 2020-12-28 | |||||||||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||||||||||||||
| 2019-09-30 | $78.78K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $115.76K derived: sum of 2 quarters · filed 2020-12-28 | $115.76K 10-K · filed 2020-12-28 | |||||||||||||
| 2019-06-30 | $36.98K 10-Q · filed 2020-08-06 | $36.98K 10-Q · filed 2020-08-06 | ||||||||||||||
| 2016-09-30 | $61.20K 10-K · filed 2019-01-25 | |||||||||||||||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | -$20.90K derived: sum of 2 quarters · filed 2017-12-11 | $42.07K derived: sum of 3 quarters · filed 2017-12-11 | $84.84K 10-K · filed 2017-12-11 | ||||||||||||
| 2015-06-30 | -$20.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | $42.07K derived: sum of 2 quarters · filed 2016-08-11 | $84.84K 10-Q · filed 2016-08-11 | -$8.46M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2015-03-31 | $62.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $105.75K 10-Q · filed 2016-05-11 | -$8.44M derived: sum of 3 quarters · filed 2016-12-14 | -$8.43M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-12-31 | $42.77K 10-Q · filed 2016-02-08 | -$8.50M derived: sum of 2 quarters · filed 2016-12-14 | -$8.50M derived: sum of 3 quarters · filed 2016-12-14 | -$8.50M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-09-30 | -$8.55M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | -$8.54M derived: sum of 2 quarters · filed 2016-12-14 | -$8.54M derived: sum of 3 quarters · filed 2016-12-14 | -$8.54M 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $5.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $5.50K derived: sum of 2 quarters · filed 2015-08-14 | $5.50K 10-Q · filed 2015-08-14 | -$489.83K derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2014-03-31 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 10-Q · filed 2015-05-14 | -$495.33K derived: sum of 3 quarters · filed 2015-02-17 | -$495.33K derived: sum of 4 quarters · filed 2015-02-17 | -$5.01M 10-Q/A · filed 2014-05-30 | |||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-17 | -$495.33K derived: sum of 2 quarters · filed 2015-02-17 | -$495.33K derived: sum of 3 quarters · filed 2015-02-17 | -$495.33K derived: sum of 4 quarters · filed 2015-02-17 | -$5.01M 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | -$495.33K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | -$495.33K derived: sum of 2 quarters · filed 2014-12-29 | -$495.33K derived: sum of 3 quarters · filed 2014-12-29 | -$495.33K 10-K · filed 2014-12-29 | -$5.01M 10-K · filed 2013-12-30 | |||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-30 | $0.00 10-Q · filed 2013-08-14 | -$5.00 derived: sum of 4 quarters · filed 2014-05-30 | -$4.52M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | -$5.00 derived: sum of 3 quarters · filed 2014-05-30 | -$3.83M derived: sum of 4 quarters · filed 2014-05-30 | -$4.52M 10-Q · filed 2013-05-17 | |||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | -$5.00 derived: sum of 2 quarters · filed 2014-02-14 | -$3.83M derived: sum of 3 quarters · filed 2014-02-14 | -$3.83M derived: sum of 4 quarters · filed 2014-02-14 | -$4.52M 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | -$5.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | -$3.83M derived: sum of 2 quarters · filed 2013-12-30 | -$3.83M derived: sum of 3 quarters · filed 2013-12-30 | -$3.83M 10-K · filed 2013-12-30 | -$4.52M 10-K · filed 2012-12-31 | |||||||||||
| 2012-06-30 | -$3.83M 10-Q · filed 2013-08-14 | -$3.83M derived: sum of 2 quarters · filed 2013-08-14 | -$3.83M 10-Q · filed 2013-08-14 | -$3.83M derived: sum of 4 quarters · filed 2013-08-14 | -$4.52M 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-17 | $0.00 10-Q · filed 2013-05-17 | $0.00 derived: sum of 3 quarters · filed 2013-05-17 | $0.00 derived: sum of 4 quarters · filed 2013-05-17 | -$686.21K 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-14 | $0.00 derived: sum of 2 quarters · filed 2013-02-14 | $0.00 derived: sum of 3 quarters · filed 2013-02-14 | $0.00 derived: sum of 4 quarters · filed 2013-02-14 | -$686.21K 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $0.00 derived: sum of 2 quarters · filed 2012-12-31 | $0.00 derived: sum of 3 quarters · filed 2012-12-31 | -$198.74K 10-K · filed 2012-12-31 | -$686.21K 10-K · filed 2011-12-22 | |||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-17 | $0.00 derived: sum of 2 quarters · filed 2012-08-17 | -$198.74K 10-Q · filed 2012-08-17 | -$686.21K 10-Q · filed 2011-08-12 | ||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | -$198.74K 10-Q · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | $0.00 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |